Cognex (NASDAQ:CGNX) Issues Q2 2026 Earnings Guidance

Cognex (NASDAQ:CGNX) issued an update on its second quarter 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.400-0.440 for the period, compared to the consensus EPS estimate of 0.300. The company issued revenue guidance of $280.0 million-$300.0 million, compared to the consensus revenue estimate of $269.3 million.

Cognex Trading Up 5.8%

NASDAQ:CGNX traded up $3.43 during trading hours on Wednesday, hitting $62.26. The stock had a trading volume of 6,817,557 shares, compared to its average volume of 2,124,689. Cognex has a 1-year low of $27.82 and a 1-year high of $63.01. The business has a 50 day simple moving average of $52.39 and a two-hundred day simple moving average of $44.95. The company has a market cap of $10.40 billion, a PE ratio of 92.93 and a beta of 1.48.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 11.51% and a return on equity of 9.02%. The company had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Research analysts expect that Cognex will post 0.97 EPS for the current fiscal year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 12th. Shareholders of record on Thursday, February 26th were given a $0.085 dividend. The ex-dividend date of this dividend was Thursday, February 26th. This represents a $0.34 annualized dividend and a yield of 0.5%. Cognex’s dividend payout ratio (DPR) is 50.75%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CGNX. Needham & Company LLC raised their price target on shares of Cognex from $47.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Cantor Fitzgerald reissued an “overweight” rating and set a $63.00 price target on shares of Cognex in a research report on Friday, February 13th. TD Cowen reissued a “buy” rating on shares of Cognex in a research report on Tuesday, February 17th. JPMorgan Chase & Co. raised shares of Cognex from an “underweight” rating to a “neutral” rating and set a $55.00 price target for the company in a research report on Monday, March 9th. Finally, Raymond James Financial reissued a “strong-buy” rating on shares of Cognex in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $59.50.

Insiders Place Their Bets

In other Cognex news, Director Angelos Papadimitriou sold 4,150 shares of Cognex stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $55.58, for a total value of $230,657.00. Following the completion of the transaction, the director owned 16,222 shares of the company’s stock, valued at $901,618.76. The trade was a 20.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Laura Ann Macdonald sold 14,881 shares of Cognex stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total transaction of $850,597.96. Following the completion of the transaction, the vice president directly owned 2,212 shares of the company’s stock, valued at approximately $126,437.92. This represents a 87.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 196,083 shares of company stock valued at $11,419,321 over the last 90 days. 1.70% of the stock is owned by company insiders.

Cognex News Summary

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 results beat expectations — Cognex reported $0.34 EPS vs. $0.25 consensus and revenue of $268.4M vs. $246.0M consensus, with improved margins. The print demonstrates demand resilience and drove the initial upside. Cognex Reports First Quarter 2026 Results
• Positive Sentiment: Management raised Q2 guidance well above Street estimates — EPS guidance of $0.400–$0.440 (vs. $0.300 consensus) and revenue guidance of $280M–$300M (vs. ~$269M consensus), signaling continued growth and margin visibility. This guidance lift is a key catalyst for the stock jump. Cognex Q1 Press Release / Guidance
• Positive Sentiment: New product & partner news bolsters AI/edge roadmap — Cognex launched the In-Sight® 3900, a high-performance embedded AI vision system powered by Qualcomm, which expands addressable markets for edge inspection without an external PC. Product/partnership news supports longer-term revenue and AI positioning. Cognex Launches In-Sight 3900
• Positive Sentiment: Coverage highlighting AI strategy and momentum — industry/market write-ups are emphasizing Cognex’s AI vision push and strong Q1, which can attract momentum and investor interest. Cognex Posts Strong Q1 Results and Boosts AI Vision
• Neutral Sentiment: Valuation and analyst commentary — recent articles assess CGNX’s valuation after the rally; the stock trades at a high P/E relative to history, so further upside may depend on continued execution against raised guidance. Investors should weigh growth vs. current multiple. Assessing Cognex Valuation

Institutional Investors Weigh In On Cognex

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Quadrant Capital Group LLC raised its stake in shares of Cognex by 1.0% during the fourth quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after purchasing an additional 234 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of Cognex by 12.9% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company’s stock valued at $68,000 after purchasing an additional 243 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Cognex by 0.5% during the third quarter. Public Employees Retirement System of Ohio now owns 54,349 shares of the scientific and technical instruments company’s stock valued at $2,462,000 after purchasing an additional 292 shares in the last quarter. CIBC Private Wealth Group LLC raised its stake in shares of Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after purchasing an additional 327 shares in the last quarter. Finally, Snowden Capital Advisors LLC raised its stake in shares of Cognex by 2.0% during the second quarter. Snowden Capital Advisors LLC now owns 17,326 shares of the scientific and technical instruments company’s stock valued at $550,000 after purchasing an additional 338 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.